Cargando…
Identification of potential diagnostic biomarkers in MMPs for pancreatic carcinoma
Pancreatic cancer (PC) is a malignant tumor which ranks fourth in cancer-related death. However, the specificity and sensitivity of traditional biomarkers such as carbohydrate antigen 19-9 no longer meet the clinical requirements. Tools as ONCOMINE and Gene Expression Profiling Interactive Analysis...
Autores principales: | Xie, Junhao, Zhou, Xianzhu, Wang, Rui, Zhao, Jiulong, Tang, Jian, Zhang, Qichen, Du, Yiqi, Pang, Yanan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202616/ https://www.ncbi.nlm.nih.gov/pubmed/34114996 http://dx.doi.org/10.1097/MD.0000000000026135 |
Ejemplares similares
-
Comparison of diagnostic accuracy of 3 diagnostic criteria combined with refined pathological scoring system for drug-induced liver injury
por: Liu, Yiqi, et al.
Publicado: (2020) -
Metabolomic biomarkers for hepatocellular carcinoma: A systematic review
por: Feng, Ningning, et al.
Publicado: (2022) -
A CARE-compliant case report: total pancreatectomy and total gastrectomy to treat pancreatic ductal adenocarcinoma
por: Wen, Yanghui, et al.
Publicado: (2019) -
Prognostic value of pretreatment skeletal muscle index in pancreatic carcinoma patients: A meta-analysis
por: Yang, Li, et al.
Publicado: (2023) -
TYMS presents a novel biomarker for diagnosis and prognosis in patients with pancreatic cancer
por: Fu, Zhuo, et al.
Publicado: (2019)